VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 10/01/2021
** VAERS DATABASE Last updated: October 1, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.






Manufacturers

Total Manufacturer
187,133MODERNA
33,878JANSSEN
2,321PFIZER\BIONTECH
1,091GLAXOSMITHKLINE BIOLOGICALS
983UNKNOWN MANUFACTURER
363MERCK & CO. INC.
229SEQIRUS, INC.
45DYNAVAX TECHNOLOGIES CORPORATION
41NOVARTIS VACCINES AND DIAGNOSTICS
29SANOFI PASTEUR
18EMERGENT BIOSOLUTIONS
8PAXVAX
7TEVA PHARMACEUTICALS
4PFIZER\WYETH
3BERNA BIOTECH, LTD.
2SMITHKLINE BEECHAM
2INTERCELL AG
2PROTEIN SCIENCES CORPORATION
1CSL LIMITED

Incidents per State

State Total
77,548
AK1,869
AL5,581
AR3,688
AS47
AZ14,288
CA61,984
CO11,665
CT8,149
DC1,663
DE1,807
FL37,749
FM5
GA15,058
GU120
HI2,453
IA4,625
ID2,692
IL20,334
IN24,007
KS4,615
KY7,696
LA4,887
MA14,654
MD12,514
ME3,129
MH11
MI18,739
MN12,528
MO9,710
MP29
MS2,790
MT2,375
NC16,368
ND1,356
NE2,880
NH3,100
NJ17,634
NM3,916
NV4,239
NY34,355
OH19,081
OK6,195
OR8,636
PA23,083
PR2,370
QM2
RI2,088
SC6,411
SD1,212
TN9,131
TX35,174
UT4,273
VA14,937
VI64
VT1,676
WA14,909
WI11,259
WV2,388
WY861
XB5
XL1
XV2

ID: 0942749
Sex: F
Age:
State: AR

Vax Date: 01/02/2021
Onset Date: 01/06/2021
Rec V Date: 01/14/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: chills; body ache; headache; fatigue; upper chest discomfort with deep breath; This is a spontaneous report from a contactable other health professional (patient herself). A 42-year-old female patient (non-pregnant) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot# EL3246), via an unspecified route of administration on 02Jan2021 11:00 in left arm at single dose for covid-19 immunization. The patient medical history was not reported. Allergies to medications, food, or other products was no. Concomitant medication included escitalopram oxalate (LEXAPRO, 10 mg) and vitamins nos (MULTIVITAMIN). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The most recent COVID-19 vaccine was administered in pharmacy or drug store. The patient experienced symptoms chills, body ache, mild headache, fatigue, and upper chest discomfort with deep breath on 06Jan2021. Patient never had a fever. Symptoms were resolved by the next day (07Jan2021). No treatment was received for the events. All events were reported as non-serious. No follow-up attempts are possible. No further information is expected.

Other Meds: LEXAPRO; MULTIVITAMIN [VITAMINS NOS]

Current Illness:

ID: 0942750
Sex: F
Age:
State:

Vax Date: 01/07/2021
Onset Date: 01/01/2021
Rec V Date: 01/14/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025L20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: tired; sleepy; nauseous; This is a spontaneous report from a contactable other Healthcare Professional (patient). This 38-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, on 07Jan2021 at 7:00 at single dose for COVID-19 immunization. Medical history and concomitant medications were unknown. As of 08Jan2021, the patient reports she is now tired, sleepy, and nauseous. The events were reported as non-serious. Outcome was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0942751
Sex: F
Age:
State: CA

Vax Date: 12/16/2020
Onset Date:
Rec V Date: 01/14/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EL1284
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: Upper arms soreness; This is a spontaneous report from a contactable other hcp. A 39-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), lot number and expiry date: unknown, intramuscular (right arm) on 16Dec2020 07:30 at a SINGLE DOSE then the second dose via intramuscular (left arm) on 06Jan2021 08:00 at a SINGLE DOSE for covid-19 immunisation. Medical history included drug hypersensitivity from an unknown date and unknown if ongoing. There were no concomitant medications. The patient experienced upper arms soreness on an unspecified date with outcome of recovering. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 0942752
Sex: F
Age:
State: AR

Vax Date: 01/05/2021
Onset Date: 01/06/2021
Rec V Date: 01/14/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: unknown
Dose Series: UNK
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: upset stomach; mild diarrhea; This is a spontaneous report from a contactable other hcp. A 48-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), lot number=ej1686 and expiry date unknown, intramuscular (right arm) on 05Jan2021 14:00 at a SINGLE DOSE for covid-19 immunisation. Medical history included breast cancer from an unknown date and unknown if ongoing and drug hypersensitivity to Cipro from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. The patient previously took ciprofloxacin. The patient experienced upset stomach and mild diarrhea (non-serious) on 06Jan2021 22:00. The outcome of the events was recovering.

Other Meds:

Current Illness:

ID: 0942753
Sex: F
Age:
State: CA

Vax Date: 12/16/2020
Onset Date:
Rec V Date: 01/14/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: injection site soreness; This is a spontaneous report from a contactable other healthcare professional (patient). A 22-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiry date unknown) intramuscular at the right arm on 16Dec2020 11:00 at single dose for Covid-19 immunization in a hospital facility. Medical history included allergies to latex. The patient has no covid prior vaccination. The patient was not pregnant. Concomitant medications was none. The patient has no other vaccine in four weeks. The patient experienced injection site soreness on unspecified date. The patient did not receive treatment due to the event. The patient was not covid tested post vaccination. The reporter considered the event non-serious; which did not result in death, not life threatening, did not cause/prolong hospitalization, not disabling/incapacitating and no congenital anomaly/birth defect. Follow-up activities are possible, information on the batch number has been requested.

Other Meds:

Current Illness:

ID: 0942754
Sex: F
Age:
State:

Vax Date: 01/06/2021
Onset Date: 01/01/2021
Rec V Date: 01/14/2021
Hospital:

Vax Type: FLUC4
Manufacturer: SEQIRUS, INC.
Vax Name: INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT)
Lot: 276563
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: very dizzy; diarrhea; nausea; This is a spontaneous report from a contactable consumer (patient husband). A female patient of unknown age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, on 06Jan2021 at single dose for COVID-19 immunisation. Medical history and concomitant medications were unknown. The patient got very dizzy and had diarrhea and nausea and today (08Jan2021), it is worse. Outcome was not recovered. Information about Lot/Batch number has been requested.

Other Meds:

Current Illness:

ID: 0942755
Sex: F
Age:
State:

Vax Date:
Onset Date: 01/07/2021
Rec V Date: 01/14/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: Severe joint and muscle pain; Severe joint and muscle pain; It woke me up; 99.8 with a gram of Tylenol on board; This is a spontaneous report from a non-contactable nurse, the patient. A 42-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunization. The patient's medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medication included sertraline, cefixime (FLEXERIL), and paracetamol (TYLENOL). The patient did not receive any other vaccine within 4 weeks prior to the vaccination. On 07Jan2021 01:00 AM, the patient experienced severe joint and muscle pain. The patient was woken up even after taking cefixime which usually knocks the patient out (as reported). The patient had a temperature of 99.8 with a gram of paracetamol on board (as reported). The patient reported that she did not receive any treatment for the events. Since vaccination, the patient had not been tested for COVID-19. The outcome of the events severe joint, muscle pain, was woken and temperature of 99.8, were all recovering. No follow-up attempts are possible; information about lot number cannot be obtained.

Other Meds: ; FLEXERIL [CEFIXIME]; TYLENOL

Current Illness:

ID: 0942756
Sex: F
Age:
State: PA

Vax Date: 01/06/2021
Onset Date: 01/06/2021
Rec V Date: 01/14/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: body aches; Chills; low grade fever; This is a spontaneous report from a contactable consumer. A 45-year-old female patient started to receive bnt162b2 (BNT162B2, lot number EK9231), intramuscular (left deltoid) from 06Jan2021 08:30 to 06Jan2021 08:30 at 0.3 mL, single for covid-19 vaccination. Medical history included ongoing asthma. The patient also received first dose of bnt162b2 on 16Dec2020. Concomitant medication included budesonide, formoterol fumarate (SYMBICORT) and salbutamol sulfate (ALBUTEROL); both ongoing given for asthma. It was reported that the patient received the second Pfizer covid19 vaccine dose yesterday around 8:30am. She is calling to report that she experienced body aches, chills, and a low-grade fever which all started around 8pm yesterday (06Jan2021). For the treatment, she is taking Tylenol. The outcome of the events was unknown.

Other Meds: SYMBICORT; ALBUTEROL [SALBUTAMOL SULFATE]

Current Illness: Asthma

ID: 0942757
Sex: F
Age:
State: FL

Vax Date: 01/05/2021
Onset Date: 01/05/2021
Rec V Date: 01/14/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: sensed/tasted metallic; sensed/tasted metallic; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE Lot EK9231) solution for injection in the left arm on 05Jan2021 at 16:15 (at the age of 46-years-old) as a single dose for COVID-19 vaccination. The patient was not pregnant at the time of vaccination. Medical history included hypertensive. Concomitant medications included metoprolol; ascorbic acid/herbal nos/levoglutamide/lysine/magnesium/manganese/retinol/riboflavin/selenium/tocopherol/zinc (AIRBORNE); and an unspecified diuretic. The patient had no known allergies to medications, food, or other products. The patient did not receive any other vaccine within 4 weeks prior to the vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 05Jan2021 at 16:30, the patient experienced sensed/tasted metallic. The patient stated, "Immediately after the vaccine was injected, I sensed/tasted metallic. It has been four days since the injection and I still have the metallic taste." No treatment was provided for the event sensed/tasted metallic. The outcome of the event sensed/tasted metallic was not recovered. Since the vaccination, the patient has not been tested for COVID-19.

Other Meds: ; AIRBORNE

Current Illness:

ID: 0942758
Sex: M
Age:
State: TX

Vax Date: 01/02/2021
Onset Date: 01/03/2021
Rec V Date: 01/14/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J201A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: Swollen under arm and a knot/upper part of shoulder and chest area was swollen.; Nauseated; Real dehydrated; Kidneys started hurting and felt like kidneys were overworking; Mouth dry; Kept having to go to the restroom; Kept using restroom and had to pee a lot; He is a little sore, but the pain is not as bad; Pain in kidneys woke him up from sleep.; Arm is still swollen but swelling went down; red spot under his arm that looks irritated; This is a spontaneous report from a contactable consumer (patient). A 47-year-old male patient received bnt162b2 via an unspecified route of administration in upper right arm on 02Jan2021 between 07:00-07:30 at single dose for covid-19 immunization. Medical history: None. There were no concomitant medications. The patient experienced swollen under arm and a knot/upper part of shoulder and chest area was swollen on 03Jan2021 18:00, nauseated, real dehydrated, kidneys started hurting and felt like kidneys were overworking, mouth dry, kept having to go to the restroom; kept using restroom and had to pee a lot, he is a little sore, but the pain is not as bad, pain in kidneys woke him up from sleep all on 03Jan2021. Got COVID Vaccine on Saturday. Was swollen up under arm. Over kidneys, started hurting. Swelling went down. Took Naproxen and Ibuprofen. Mouth was really dry. Felt like kidneys are overworking. Keeps drinking water and going to the restroom. Kidneys started hurting. Received through work. Employed at a mental health and mental retardation school. Arm swollen with a knot. Got off Sunday morning, 03Jan2021. By 18:00, under arm was swollen. Thought he slept wrong or he had an issue with an artery. Under arm and into upper part of shoulder and chest area was swollen. He was nauseated. Felt really dehydrated. Kidneys started hurting. Felt like kidneys were overworking. Felt similar to when he previously had a kidney infection. Knew something wasn't right. Kept using restroom and had to pee a lot. Kept drinking. Kidneys were hurting from 03Jan2021 to yesterday. He is a little sore, but the pain is not as bad. Was drinking water, cranberry juice, and orange juice to flush the COVID vaccine through. Pain in kidneys woke him up from sleep. Is a little swollen. Pain is better than what it was. Between 02:00-03:00 it was done. Swelling was really bad. Start taking Naproxen and Ibuprofen. He was hurting too. Arm is still swollen but swelling went down. There is a red spot under his arm that looks irritated. Supposed to receive second COVID Vaccine on 30Jan2021 but was not going to take it. Clarified he took Naproxen with Ibuprofen in it for the anti-inflammatory. Confirmed he was only referring to one product. Naproxen was just bought from the store. Unable to provide NDC/Lot/Exp because he does not have product at time of call. Formulation: 200mg per pill, took two pills then six hours later took another two for Voluntary; high number of COVID Cases at his work. Scared to take second COVID Vaccine. The patient underwent lab tests and procedures which included Covid Test: unknown results on an unspecified date (He has to take COVID tests twice a week). The outcome of events was unknown. Vaccination Facility Type: which is a mental health and mental retardation school. He has to take COVID tests twice a week. No additional vaccines administered on same date of Pfizer suspect. The event was not required a visit to doctor or other healthcare professional office/clinic or Emergency room/department or urgent care. Prior vaccinations within 4 weeks was none. Adverse event follow prior vaccinations was none. Relevant tests: none. Information about Lot/Batch number has been requested.

Other Meds:

Current Illness:

ID: 0942759
Sex: M
Age:
State: MA

Vax Date: 01/06/2021
Onset Date: 01/07/2021
Rec V Date: 01/14/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: when I stand up or walk, I become dizzy; This is a spontaneous report from a contactable health care professional, the patient. A 39-years-old male patient (health care professional) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot Number: ek9231), intramuscular in the left arm on 06-JAN-2021 12:45 as a single dose, for COVID-19 vaccination. The vaccine was administered at a hospital. Medical history includes drug hypersensitivity to sulfa drugs. There were no concomitant medications. No other vaccines were given within 4 weeks. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination the patient had not been tested for COVID-19. On 07-JAN-2021 03:00, the patient experienced when I stand up or walk, I become dizzy. No treatment was given for the event. The clinical outcome of when I stand up or walk, I become dizzy was not recovered.

Other Meds:

Current Illness:

ID: 0942760
Sex: M
Age:
State: PA

Vax Date: 01/04/2021
Onset Date: 01/06/2021
Rec V Date: 01/14/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039k20a
Dose Series: 1
Vax Route: SYR
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Rash, Urticaria

Symptoms: Chills; Weakness; Headache; This is a spontaneous report from a contactable consumer (patient). A 67-year-old male patient received bnt162b2 (BNT162B2 reported as Pfizer BioNTech COVID 19 vaccine; lot number: EJ1688; expiration date: unknown), intramuscular injection in left deltoid on 04Jan2021 16:00 at a single dose for preventative (covid-19 vaccination). The patient has no medical history and concomitant medications. The patient reported that he received Pfizer BioNTech COVID 19 vaccine in a hospital on 04Jan2020 at 16:00. He started experiencing chills, weakness, and a headache two days (06Jan2021) after he was administered the vaccine. The patient did not received treatment. He mentioned that he went to a physician office since he did go to urgent care and was just told not to go back to work and stay home for 2 days. The doctor from urgent care he saw this morning (unspecified date) said he would send the notes to his primary doctor when querying dose and the patient mentioned he thinks he was told the dose was 1 cc, but he is not sure. He had a COVID PCR test this morning and he does not have results yet. He wanted to get permission to go back to work. The patient underwent lab tests and procedures which included COVID PCR test was unknown result on Jan2021. The patient did not have additional vaccines administered on the same date of the Pfizer Suspect. The outcome of the event weakness was not recovered while the outcome of the other events was recovering.

Other Meds:

Current Illness:

ID: 0942761
Sex: F
Age:
State: FL

Vax Date: 01/07/2021
Onset Date: 01/07/2021
Rec V Date: 01/14/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: Fever (T-max 100.4); headache; body aches; This is a spontaneous report from a contactable health care professional, the patient. A 29-years-old non-pregnant female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot Number: EL1284) in the left arm on 07Jan2021 as a single dose, for COVID-19 vaccination. The vaccine was administered at a Hospital. Medical history included Stiff-man syndrome, polycystic ovarian syndrome and known allergies to soy, sesame, and walnuts. Concomitant medication included tramadol (TRAMADOL), gabapentin (GABAPENTIN), methocarbamol (ROBAXIN), dienogest, estradiol valerate (NATAZIA), insulin (INSULIN). The patient previously experienced drug hypersensitivity to Penicillin, Neosporin, and Levaquin. The patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot Number: EH9899), in the left arm on 17Dec2020 11:AM. No other vaccines were given within 4 weeks except the first dose of BNT162B2. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination the patient had not been tested for COVID-19. On 07Jan2021 17:30, the patient experienced fever (t-max 100.4), headache and body aches. Lab data include body temperature: t-max 100.4 on 07Jan2021. No treatment was given for the events. The clinical outcome of the events fever (t-max 100.4), headache and body aches was recovering.

Other Meds: ; ; ROBAXIN; NATAZIA;

Current Illness:

ID: 0942762
Sex: F
Age:
State: MO

Vax Date: 12/21/2020
Onset Date: 12/27/2020
Rec V Date: 01/14/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20-2A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: Multiple, large, hard and soft swollen lymph nodes in neck and above and below clavicle in same arm as vaccine given; severe aches and pains in neck and upper back; severe aches and pains in neck and upper back; This is a spontaneous report from a contactable nurse (patient). A 59-year-old non-pregnant female patient received her first dose of bnt162b2 (BNT162B2 reported as COVID-19 vaccine; lot number: EH9899; expiration date: unknown), via an unspecified route of administration right arm on 21Dec2020 12:00 PM at a single dose for covid-19 vaccination. Medical history included latex allergy. The patient's concomitant medications were not reported. The patient previously took telithromycin (KETEKS) and clonidine, but both had allergies. The patient received the most recent COVID-19 vaccine administered in a hospital. The patient reported that she had multiple large, hard and soft swollen lymph nodes in neck and above and below clavicle in same arm as vaccine given, severe aches and pains in neck and upper back on 27Dec2020. The patient did not received treatment for the adverse event. The events were considered as non-serious. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 and has not been tested for COVID-19 since the vaccination. The adverse event resulted in a doctor or other healthcare professional office/clinic visit. The outcome of the events was recovering.

Other Meds:

Current Illness:

ID: 0942763
Sex: F
Age:
State:

Vax Date: 01/07/2021
Onset Date: 01/07/2021
Rec V Date: 01/14/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: pain/excruciating pain in her bones, and all over her body; pain in her bones; under her arm was swollen; under her arm was swollen and very painful; having pain in her breast; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 07Jan2021 at single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. Patient got her second COVID vaccine shot on 07Jan2021, and was in pain and under her arm was swollen and very painful and she was having pain in her breast as well. Patient was in excruciating pain in her bones, and all over her body. Caller was taking paracetamol (TYLENOL) but that didn't help too much. Outcome of all events was not recovered. Information about batch/lot number has been requested.

Other Meds:

Current Illness:

ID: 0942764
Sex: F
Age:
State: PA

Vax Date: 01/06/2021
Onset Date: 01/07/2021
Rec V Date: 01/14/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: whole upper arm redness and swelling/arm redness at the injection site; whole upper arm redness and swelling/inflamed swelling to her upper arm; arm redness at the injection site, about 10cm-12cm in size, became a baseball size in diameter with redness and induration; whole upper arm redness and swelling/inflamed swelling to her upper arm; This is a spontaneous report from a contactable physician. A female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration on 06Jan2021 as a single dose in the arm for COVID-19 vaccination. Medical history and concomitant medications were not reported. On 07Jan2021, the patient experienced whole upper arm redness and swelling following administration of BNT162B2. On 07Jan2021, she began having arm redness at the injection site, about 10cm-12cm in size, became a baseball size in diameter with redness and induration. It was reported that no, the patient has whole upper arm redness and inflamed swelling to her upper arm. It was reported that the side effect is a very swollen red arm, all around the arm, it is very indurated all the way around her arm. The clinical outcome of whole upper arm redness and swelling/arm redness at the injection site and arm redness at the injection site, about 10cm-12cm in size, became a baseball size in diameter with redness and induration was unknown. The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.

Other Meds:

Current Illness:

ID: 0942765
Sex: M
Age:
State: MI

Vax Date: 01/07/2021
Onset Date: 01/08/2021
Rec V Date: 01/14/2021
Hospital:

Vax Type: DTAPHEPBIP
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: DTAP + HEPB + IPV (PEDIARIX)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: Developed fever 102.7 F; Chills; Extreme weakness; This is a spontaneous report from a contactable healthcare professional who reported for himself, a 62-year-old male patient who received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EL0140) at the hospital, via an unspecified route of administration in the left arm on 07Jan2021 09:00 at a single dose for COVID-19 immunization. Medical history included CVA no residual, patent foramen ovale and known allergies to iodine. Concomitant medications included apixaban (ELIQUIS) and atorvastatin (ATORVASTATIN). Patient did not receive other vaccines in four weeks. On 08Jan2021 at 06:00 AM, the patient developed fever 102.7 F, chills and extreme weakness. Treatment for the events included Tylenol, tepid bath and "cleep". Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The events were reported as non-serious. The outcome of the events was not recovered.

Other Meds: ELIQUIS;

Current Illness:

ID: 0942766
Sex: M
Age:
State: CA

Vax Date: 01/06/2021
Onset Date: 01/07/2021
Rec V Date: 01/14/2021
Hospital:

Vax Type: HIBV
Manufacturer: MERCK & CO. INC.
Vax Name: HIB (PEDVAXHIB)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: woke up with Mild chills; body aches for 12 hours; This is a spontaneous report from a contactable other healthcare professional, the patient. A 54-year-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), lot number: EH9899, via intramuscular on 06Jan2021 at 07:30 (at the age of 54 years old) as a single dose in the left arm for COVID-19 vaccination. Medical history included enlarged prostate from an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medication included tamsulosin, Vitamin D-3, Vitamin C, and montelukast sodium (SINGULAIR), all for unknown indications from unknown dates and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination, but did receive the first dose of BNT162B2 with lot number: EH9899 on 16Dec2020 at 16:30, intramuscular in left arm. The vaccine was given at a hospital. On 07Jan2021 at 06:00, the patient woke up with mild chills, and body aches for 12 hours. The patient did not receive treatment for the events. The clinical outcome of mild chills, and body aches for 12 hours was recovered. It was also reported that since the vaccination, the patient had not been tested for COVID-19.

Other Meds: SINGULAIR; ; VITAMIN C [ASCORBIC ACID]; VITAMIN D3

Current Illness:

ID: 0942767
Sex: F
Age:
State: SC

Vax Date: 01/06/2021
Onset Date: 01/07/2021
Rec V Date: 01/14/2021
Hospital:

Vax Type: PNC13
Manufacturer: PFIZER\WYETH
Vax Name: PNEUMO (PREVNAR13)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: Arm soreness; Huge headache; Low grade fever (99.5); Felt cold, couldn't get warm; chills; Stabbing, shooting pain in right parotid glands; General feeling of unwellness; This is a spontaneous report from a contactable nurse. A 54-years-old female patient started to the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), lot EL0142, on 06Jan2021 (at the age of 54-years-old) as a single dose in the right arm for COVID-19 immunization. Medical history included chronic granulomatous disease. Concomitant medication were unspecified. The patient previously received the first dose of BNT162B2, Lot number: EK5730, on 17Dec2020, administration time: 08:00 AM, in the left arm for covid-19 immunization. The patient previously took Oxacillin and Levaquin and experienced allergies. The most recent COVID-19 vaccine was administered in the workplace clinic. The patient was not pregnant at the time of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. On 07Jan2021 09:30, the patient experienced arm soreness, huge headache, Low grade fever (99.5), Felt cold, couldn't get warm, chills, Stabbing, shooting pain in right parotid glands and General feeling of unwellnessThe events arm soreness, Huge headache, Low grade fever (99.5), Felt cold, couldn't get warm, chills, Stabbing, shooting pain in right parotid glands and General feeling of unwellness did not result in death, was not life-threatening, did not cause/prolonged hospitalization, was not disabling/incapacitating and did not cause congenital anomaly/birth defect. No treatment was received for the events. Outcome of the events arm soreness, Huge headache, Low grade fever (99.5), Felt cold, couldn't get warm, chills, Stabbing, shooting pain in right parotid glands and General feeling of unwellness was recovered. Since the vaccination, the patient has not been tested for COVID-19.

Other Meds:

Current Illness:

ID: 0942768
Sex: M
Age:
State: IN

Vax Date: 01/06/2021
Onset Date: 01/06/2021
Rec V Date: 01/14/2021
Hospital:

Vax Type: RV1
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: ROTAVIRUS (ROTARIX)
Lot:
Dose Series: 1
Vax Route: PO
Vax Site: MO

Lab Data:

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: Patient reported fatigue the day of the 1st injection; This is a spontaneous report from a contactable healthcare professional. An adult male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date unknown) at the hospital, intramuscular in the left arm on 06Jan2021 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient had no known allergies. Patient reported fatigue the day of the 1st injection on 06Jan2021. No other symptoms were reported. No treatment was received for the event. The event was reported as non-serious. Since the vaccination, the patient has not been tested for COVID-19. The patient recovered from the event on an unspecified date. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 0942769
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 01/14/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: Eh9899
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: throat tightness; This is a spontaneous report from a non-contactable other hcp. A 60-year-old female patient received BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine) (Lot number not provided), dose #2, intramuscularly in the right deltoid on an unspecified date (at an unspecified age) as a single dose for COVID-19 vaccination. The patient's medical history and concomitant medications were not reported. The patient previously received BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine) (lot number: EK9231), dose #1, via an unspecified route of administration on an unspecified date as a single dose for COVID-19 vaccination. On an unspecified date, the patient was given vaccination dose #2 in the right deltoid muscle. During her 15 minute waiting period following the injection, the patient began to experience throat tightness. She denied rash, hives, welts, difficulty breathing, difficulty swallowing, wheezing, hoarseness, stridor, itching, lightheadedness, dizziness, facial swelling, lip swelling and tongue swelling. Therapeutic measures taken as a result of the event was antihistamines and bendadryl. Folllow-up response to treatment: no side effects. The patient was assessed as stable to go home and was discharged. The clinical outcome of the throat tightness was unknown. No follow-up attempts are possible. No further information is expected. Information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 0942770
Sex: F
Age:
State: UT

Vax Date: 12/18/2020
Onset Date: 12/20/2020
Rec V Date: 01/14/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Unevaluable event

Symptoms: chills; body aches; headache; nausea; fatigue; This is a spontaneous report from a contactable Physician, the patient. This 29-year-old female patient received BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine) (Lot number: EK5730) (dose #1), via an unspecified route of administration in the right arm on 18Dec2020 at 14:30 (at the age of 29-years-old) as a single dose for COVID-19 vaccination. The patient's medical history was not reported. Concomitant medication included cetirizine hydrochloride (ZYRTEC SUMITOMO), levonorgestrel (KYLEENA), melatonin (MELATONIN), spironolactone (SPIRONOLACTONE). Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient previously took Celebrex for an unknown indication and experienced drug hypersensitivity. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient was not pregnant at the time of vaccination. On 20Dec2020 at 10:00, 44 hours after receiving the vaccine, the patient developed chills, body aches, headache, nausea and fatigue. These symptoms persisted for 5 days total. She was not febrile at any time. The adverse events resulted in a doctor or other healthcare professional/clinic visit. No therapeutic measures were taken as a result of the events. The clinical outcome of chills, body aches, headache nausea and fatigue was resolved on 25Dec2020. It was also reported that since the vaccination, the patient had been tested for COVID-19: negative on 21Dec2020 (saliva test) and negative on 22Dec2020 (nasal swab test).

Other Meds: ZYRTEC SUMITOMO; KYLEENA; ;

Current Illness:

ID: 0942771
Sex: F
Age:
State: MN

Vax Date: 01/04/2021
Onset Date: 01/01/2021
Rec V Date: 01/14/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: Pain in arm like a tents shot for about a day and a half; headache; dizziness; This is a spontaneous report from a contactable other hcp, the patient. This 19-year-old female patient received BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine) (Lot number: EK4176) (dose #1), via an unspecified route of administration in the left arm on 04Jan2021 at 19:00 (at the age of 19-years-old) as a single dose for COVID-19 vaccination. Medical history included depression from an unknown date and unknown if ongoing, panic disorder from an unknown date and unknown if ongoing and a weak immune system from an unknown date and unknown if ongoing. The patient did not have any allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient was not pregnant at the time of vaccination. Concomitant medication included escitalopram oxalate (LEXAPRO) and an unspecified antiacid. On an unspecified date in Jan2021, the patient experienced pain in arm like a tents shot about a day and half, some headache and dizziness the first few hour. No pain or symptoms reported after 3 days following the vaccination first dose. No therapeutic measures were taken as a result of the events. The clinical outcome of pain in arm like a tents shot about a day and half, some headache and dizziness was resolved on an unspecified date in Jan2021. It was also reported that since the vaccination, the patient had not been tested for COVID-19. No follow-up attempts are possible. No further information is expected.

Other Meds: LEXAPRO

Current Illness:

ID: 0942772
Sex: M
Age:
State: FL

Vax Date: 01/07/2021
Onset Date: 01/07/2021
Rec V Date: 01/14/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011L20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: Headache; some mild jaw pain, like a dull tooth ache/jaw/tooth pain; some mild jaw pain, like a dull tooth ache/jaw/tooth pain; This is a spontaneous report from a contactable consumer reporting for himself. A 66-year-old male patient started to receive the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number: unknown) via an unspecified route of administration (left arm) on 07Jan2021 at SINGLE DOSE for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Patient wanted to know if there was a known jaw or tooth pain side effects after receiving the COVID vaccine. 15 minutes after injection, he started having mild jaw pain, described as a dull tooth ache, that has not subsided yet (24 hours later). Patient reported that the jaw/tooth pain is making him eat on the other side this morning. Patient stated he was seeking some reassurance. He mentioned he thought he was a tough guy and would not have side effects but within 2 minutes (also reported within 60 seconds or less than 5 minutes of receiving the vaccine) he had a headache. When he developed the headache, he did pull over and waited it out, but he stated that before he left the clinic after getting his vaccine, he did have some mild jaw pain, like a dull tooth ache, and he still feels it. He stated that he does not believe it could be a tooth problem, and that it had to have been triggered by the vaccine because it occurred 15 minutes after he got the vaccine. Patient was wondering if there are any know jaw problem side effects with the vaccine. He stated that it feels like a dull pain on just one side. Outcome of the event some mild jaw pain, like a dull tooth ache/jaw/tooth pain was not recovered while unknown for headache. Information about Batch/Lot number has been requested.

Other Meds:

Current Illness:

ID: 0942773
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 01/14/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: The sore deltoid side effect is moderate; This is a spontaneous report from a contactable other healthcare professional (patient herself). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number: unknown), via an unspecified route of administration on an unspecified date single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient experienced the sore deltoid side effect is moderate on an unspecified date. Patient stated that having this happen yearly may deter some people from getting the vaccine especially those who must utilize both arms during their occupation such as herself and other health professionals. Nonetheless, having two doses to take weeks apart. Event outcome was unknown. Information about lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0942774
Sex: M
Age:
State: MI

Vax Date: 01/06/2021
Onset Date: 01/06/2021
Rec V Date: 01/14/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: Lightheaded; sinus discomfort; This is a spontaneous report from a contactable consumer reporting for himself. A 75-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) (lot number Ek9231/expiration date: not provided), via an unspecified route of administration, on 06Jan2021 at 10:00 AM (at the age of 75 years old) as a single dose in the arm for COVID-19 vaccination. Relevant medical history included prostate cancer and rheumatoid arthritis. The patient has a known allergy to sulphar. Prior to the vaccination, the patient was diagnosed with COVID-19, on an unspecified date. Concomitant medication was not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 06Jan2021, at 04:00 PM, the patient was lightheaded the first day with some sinus discomfort. The patient did not receive any treatment for these events. The outcome of the events lightheaded and sinus discomfort was recovering. Since the vaccination, the patient had not been tested for COVID-19.

Other Meds:

Current Illness:

ID: 0942775
Sex: M
Age:
State: MA

Vax Date: 01/06/2021
Onset Date: 01/08/2021
Rec V Date: 01/14/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: Painful axillary lymph node swelling; Painful axillary lymph node swelling; This is a spontaneous report from a contactable physician reporting for himself. A 31-year-old male received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) (lot number: ek9231/expiration date: not provided), via intramuscular route of administration, on 06Jan2021 at 08:00 AM (at the age of 31 years old) as a single dose in the left arm for COVID-19 vaccination. Relevant medical history was none. The patient did not have any known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medication was not provided. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) (lot number/expiration date: not provided), via an unspecified route of administration, on 07Dec2020 at 08:15 AM (at the age of 31 years old) as a single dose for COVID-19 vaccination. The patient did not receive any other vaccines within 4 weeks prior to the second dose of COVID vaccine (except for the first dose of BNT162B2). On 08Jan2021, at 04:00 AM, the patient experienced painful axillary lymph node swelling, ipsilateral to injection. The patient received ibuprofen as treatment for the event painful axillary lymph node swelling. The outcome of the event painful axillary lymph node swelling was recovering. Since the vaccination, the patient had not been tested for COVID-19.

Other Meds:

Current Illness:

ID: 0942776
Sex: F
Age:
State: MI

Vax Date: 01/01/2021
Onset Date: 01/01/2021
Rec V Date: 01/14/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: Incredibly strong salty taste in mouth which started approximately 1 hour after vaccination...still persists...; This is a spontaneous report from a contactable nurse. A 68-years-old female patient started to the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), lot number: EK9231, intramuscularly on 01JAN2021 16:15 (at the age of 68-years-old) as a single dose in the left arm for COVID-19 immunization. Medical history includes Type II diabetes mellitus, Chronic bronchitis, coronary artery disease (CAD). The patient previously took Gemfibrozil and experienced allergies. Concomitant medication included unspecified medications. The most recent COVID-19 vaccine was administered in the hospital. The patient was not pregnant at the time of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. On 01JAN2021 17:00, the patient experienced incredibly strong salty taste in mouth which started approximately 1 hour after vaccination...still persists. The incredibly strong salty taste in mouth which started approximately 1 hour after vaccination...still persists did not result in death, was not life-threatening, did not cause/prolonged hospitalization, was not disabling/incapacitating and did not cause congenital anomaly/birth defect. No treatment was received for the event. Outcome of the event incredibly strong salty taste in mouth which started approximately 1 hour after vaccination...still persists was not recovered. Since the vaccination, the patient has not been tested for COVID-19.

Other Meds:

Current Illness:

ID: 0942777
Sex: F
Age:
State:

Vax Date: 01/06/2021
Onset Date: 01/01/2021
Rec V Date: 01/14/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: my arm started to ache that night, slowly travelling down my arm and into my hand; my arm started to ache that night, slowly travelling down my arm and into my hand; This is a spontaneous report from a non-contactable consumer, the patient. An elderly female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration on 06Jan2021 as a single dose for COVID-19 immunization. The patient medical history was not reported. The patient was not pregnant at the time of vaccination. Concomitant medication taken within two weeks of vaccination was unknown. It was unknown whether patient received any other vaccines within four weeks prior to the vaccination. The patient reported that the only side effect was her arm started to ache that night, slowly travelling down her arm and into her hand", in Jan2021. It was gone when she awoke in the morning. The events were reported as non-serious. The patient did not receive any treatment for her arm started to ache that night, slowly travelling down her arm and into her hand. The clinical outcome of "her arm started to ache that night, slowly travelling down her arm and into her hand" was recovered on an unspecified date in Jan2021. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 0942778
Sex: F
Age:
State: HI

Vax Date: 01/07/2021
Onset Date: 01/07/2021
Rec V Date: 01/14/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Nausea

Symptoms: Soreness to injection site; Headache, mild; This is a spontaneous report from a contactable nurse, the patient. A 37-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via unspecified route of administration, on 07Jan2021 at 17:00 PM (at the age of 37-year-old) as a single dose for COVID-19 immunization. Medical history included asthma, and polycystic ovaries. The patient was not pregnant at the time of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medication taken within two weeks of vaccination included cetirizine hydrochloride (ZYRTEC), ascorbic acid, betacarotene, calcium sulfate, colecalciferol, cyanocobalamin, ferrous fumarate, folic acid, nicotinamide, pyridoxine hydrochloride, retinol acetate, riboflavin, thiamine mononitrate, tocopheryl acetate, zinc oxide (PRENATAL VITAMINS), ubidecarenone (COQ10). The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not have any allergies to medications, food, or other products. On 07Jan2021 at 21:00 PM, the patient experienced headache, mild. It started 4-5 hours after, continued to next day. The next day, 08Jan2021 the patient experienced soreness to injection site. The events were reported as non-serious. The patient did not receive any treatment for the headache, mild and soreness to injection site. The clinical outcome of the events headache, mild and soreness to injection site was recovering. It was also reported that since the vaccination, the patient had not been tested for COVID-19. Information on the Lot/Batch number has been requested

Other Meds: ZYRTEC [CETIRIZINE HYDROCHLORIDE]; PRENATAL VITAMINS [ASCORBIC ACID;BETACAROTENE;CALCIUM SULFATE;COLECALCIFEROL;CYANOCOBALAMIN;FERROUS ; COQ10 [UBIDECARENONE]

Current Illness:

ID: 0942779
Sex: M
Age:
State: CA

Vax Date: 01/07/2021
Onset Date: 01/07/2021
Rec V Date: 01/14/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain

Symptoms: Mildly feverish evening after vaccine; Soreness and tenderness at left arm injection site; This is a spontaneous report from a contactable physician (patient). A 61-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; second dose (lot number: EL1284, expiry date: unknown) via an unspecified route of administration on 07Jan2021 07:00 at single dose (Left arm) for COVID-19 immunization. Patient took bnt162b2 first dose (lot number: EK5730, expiry date: unknown) on 17Dec2020 07:00 am (Left arm) for COVID-19 immunization. Medical history included known allergies: Sulfa, Hypothyroid, Asthma, Hi Cholesterol. Concomitant medication included cetirizine hydrochloride (ZYRTEC), atorvastatin, levothyroxine. The patient previously took tamiflu and experienced allergies. Facility type vaccine was hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient experienced Mildly feverish evening after vaccine, Soreness and tenderness at left arm injection site on 07Jan2021. The patient took Motrin as treatment. Therapeutic measures were taken as a result of mildly feverish evening after vaccine, soreness and tenderness at left arm injection site. The outcome of the events was recovered on an unspecified date. The events were reported as non-serious.

Other Meds: ; ; ZYRTEC [CETIRIZINE HYDROCHLORIDE]

Current Illness:

ID: 0942780
Sex: M
Age:
State: CA

Vax Date: 01/06/2021
Onset Date: 01/06/2021
Rec V Date: 01/14/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Left axillary lymphadenopathy pain and swelling extending into the left pectoral muscle.; Left axillary lymphadenopathy pain and swelling extending into the left pectoral muscle.; Left axillary lymphadenopathy pain and swelling extending into the left pectoral muscle.; Left axillary lymphadenopathy pain and swelling extending into the left pectoral muscle.; Date of start of drug: 06Jan2021; Date of start of drug: 06Jan2021; This is a spontaneous report from a contactable Other healthcare professional (patient). A 41-year-old male patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EJ1685), via an unspecified route of administration on 06Jan2021 09:00 in left arm at single dose for covid-19 immunization. There were no medical history, known allergies or concomitant medications in two weeks. There was no other vaccine in four weeks. The patient previously took the first dose of bnt162b2 on 19Dec2020 12:00 PM in left arm (Batch/lot number: EJ1685) for COVID-19 immunization. The patient experienced left axillary lymphadenopathy pain and swelling extending into the left pectoral muscle on 07Jan2021 07:00. The patient underwent lab tests and procedures which included Covid antibody blood test: negative on 23Dec2020. The events did not resulted in emergency room or physician visit. The events was reported as non-serious. There was no treatment for left axillary lymphadenopathy pain and swelling extending into the left pectoral muscle. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The outcome of left axillary lymphadenopathy pain and swelling extending into the left pectoral muscle were not resolved.

Other Meds:

Current Illness:

ID: 0942781
Sex: F
Age:
State: CO

Vax Date: 01/07/2021
Onset Date: 01/07/2021
Rec V Date: 01/14/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011j20a
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: when she was given the injection her cyst "bubbled up"; she believes that it was inadvertently given subcutaneously; This is a spontaneous report from a contactable nurse (patient). A 60-year-old female patient received 2nd dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; lot/batch and expiration date unspecified), subcutaneous on 07Jan2021 at single dose at left arm for COVID-19 immunization. Medical history included history of cyst on her upper left arm. The patient's concomitant medications were not reported. The patient previously received first dose of bnt162b2 on an unspecified date for COVID-19 immunization. The patient reported that when she was given the injection, her cyst "bubbled up" on an unspecified date. She believed that it was inadvertently given subcutaneously. She wanted more information on the effectiveness of the vaccine if given subcutaneously. Outcome of event when she was given the injection her cyst "bubbled up" was unknown. Information on the Lot/Batch number has been requested.

Other Meds:

Current Illness:

ID: 0942782
Sex: F
Age:
State: CA

Vax Date: 12/22/2020
Onset Date: 12/22/2020
Rec V Date: 01/14/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Tremor

Symptoms: Sore arm; This is a spontaneous report from a contactable healthcare professional (patient). A 54-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; lot EL0140, expiration date unspecified), via an unspecified route of administration on 22Dec2020 at 13:30 at single dose at left arm for COVID-19 immunization. Medical history included hypertension and hypothyroidism. The patient had no known allergies and no allergies to medications, food or other products and patient was not pregnant. The patient's concomitant medications were not reported. On 22Dec2020 at 13:30, the patient experienced sore arm. There was no therapy received for the event. The most recent COVID-19 vaccine was administered at the hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine and patient had other medications that was received within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient has not been tested for COVID-19. Outcome of event was recovered on an unspecified date.

Other Meds:

Current Illness:

ID: 0942783
Sex: F
Age:
State: CA

Vax Date: 01/06/2021
Onset Date: 01/06/2021
Rec V Date: 01/14/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: Severe myalgia; arthralgia; body stiffness; pain/pain under right axilla, extending to right chest and neck; fatigue; Nausea; food aversion; Moderate/severe lymph node swelling and pain under right axilla, extending to right chest and neck; Moderate/severe lymph node swelling and pain under right axilla, extending to right chest and neck; first dose on 18Dec2020 15:30, second dose on 06Jan2021 12:15; This is a spontaneous report from a contactable other health professional (patient). A 53-year-old female patient (not pregnant) received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EH9899), via an unspecified route of administration on 06Jan2021 12:15 in right arm at single dose for COVID-19 immunization. Medical history included ADHD (attention deficit hyperactivity disorder), depression in remission, Known allergies: yes: Nitrofurantoin, cephalexin, penicillin. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not have COVID tested post vaccination and did not have COVID prior vaccination. Concomitant medication included ashwagandha (ASHWAGANDHA), rhodiola rosea (RHODIOLA). The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 18Dec2020 15:30 for COVID-19 immunization. Adverse event on 07Jan2021 01:00: Severe myalgia, arthralgia, body stiffness, pain and fatigue in early AM of 07Jan2021, continuing into 08Jan2021, though improving. Nausea and food aversion on 07Jan2021, Moderate/severe lymph node swelling and pain under right axilla, extending to right chest and neck still evolving as of this report. Treatment: Ibuprofen OTC, bed rest, warm showers, rest. The outcome of the events was recovering.

Other Meds: ; RHODIOLA [RHODIOLA ROSEA]

Current Illness:

ID: 0942784
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 01/14/2021
Hospital:

Vax Type: UNK
Manufacturer: UNKNOWN MANUFACTURER
Vax Name: VACCINE NOT SPECIFIED (NO BRAND NAME)
Lot:
Dose Series: UNK
Vax Route: SYR
Vax Site: UN

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: fatigue; This is a spontaneous report from a non-contactable consumer (patient). A 40-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiry date: unknown), via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient was not pregnant at the time of vaccination. On an unspecified date, the patient experienced fatigue with outcome of recovering. The patient did not receive any treatment for the event. The event was assessed as non-serious. No follow-up attempts are possible, information about batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 0942785
Sex: F
Age:
State: OH

Vax Date: 01/04/2021
Onset Date: 01/06/2021
Rec V Date: 01/14/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: mild nausea; dizziness/dizzy; This is a spontaneous report from the Pfizer-Sponsored program, received by a contactable consumer (patient). A 71-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number E10142), via an unknown route, on 04Jan2021 at single dose in the left arm for COVID-19 immunisation. The patient received tetanus vaccine (at single dose in the right arm for tetanus immunization, due to overdue) in Dec2020 (3-4 weeks before vaccination for COVID-19). No additional medical history was provided. No relevant concomitant medications were provided. On 06Jan2021, she developed dizziness, she started feeling dizzy. On 07Jan2021, the patient developed mild nausea to the point that if she was laying on her right to turn on her left that her head was dizzy. The patient stated that she could not go in the bathroom at all last night because she could not make it due to dizziness. She stated that she had to pee in a cup. The patient reported that her niece, aged 27, with a history of vertigo also experienced severe dizziness after her first shot (reported under AER#2021015495). The patient had recovered from mild nausea on 07Jan2021 while she was recovering from dizziness/dizzy.

Other Meds:

Current Illness:

ID: 0942786
Sex: F
Age:
State: CA

Vax Date: 01/07/2021
Onset Date: 01/07/2021
Rec V Date: 01/14/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: neck stiffness; coughing with production of white mucous; felt like she couldn't breath with tightness for about a half hour; felt like she couldn't breath with tightness for about a half hour; This is a spontaneous report from a contactable consumer. A 68-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; lot /batch and expiration date unspecified), via an unspecified route of administration on 07Jan2021 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient reported that she got the vaccine yesterday (07Jan2021) and that a couple of hours later she began to experience neck stiffness, coughing with production of white mucous and felt like she couldn't breath with tightness for about a half hour. The patient was asking if this was normal. Outcome of events was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0942787
Sex: F
Age:
State: PA

Vax Date: 12/24/2020
Onset Date: 12/25/2020
Rec V Date: 01/14/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Fever; chills; This is a spontaneous report from a contactable nurse (patient). A 46-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EK9231), intramuscular on 24Dec2020 14:30 (reported as "02:30 PM") at single dose on left arm as COVID vaccine. Patient was not pregnant. Medical history included asthma and hypothyoridism. The patient was diagnosed with COVID-19 prior to vaccination. Concomitant medications included levothyroxine sodium (SYNTHROID), fluticasone furoate, vilanterol trifenatate (BREO ELLIPTA), reported as "Other medications in twoweeks: synthroid, Breo". The patient previously took cefalexin (KEFLEX) and experienced allergies. The patient experienced fever and chills on 25Dec2020 at "08:00PM". The events were assessed as non-serious. No treatment was given. Since the vaccination, the patient has not been tested for COVID-19. Outcome of the events was recovered on an unspecified date.

Other Meds: SYNTHROID; BREO ELLIPTA

Current Illness:

ID: 0942788
Sex: U
Age:
State:

Vax Date: 01/01/2021
Onset Date: 01/01/2021
Rec V Date: 01/14/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EK9231
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: body aches; chills; headaches; migraines; This is a spontaneous report from a contactable consumer. An adult patient of an unspecified gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date were not reported), via an unspecified route of administration on Jan2021 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced body aches, chills, headaches and migraines on Jan2021 with outcome of recovering. The events was considered non-serious. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0942789
Sex: F
Age:
State: NC

Vax Date: 01/08/2021
Onset Date: 01/08/2021
Rec V Date: 01/14/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pain in extremity

Symptoms: Burning after injection; This is a spontaneous report from a contactable pharmacist. A 38-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), lot number: EK9231, intramuscular in the left arm, from 08Jan2021 at a single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient is not pregnant. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, has the patient has not been tested for COVID-19. The patient experienced burning after injection on 08Jan2021. The outcome of event was recovering. No follow-up attempts possible. No further information expected. Information on the batch number has been obtained.

Other Meds:

Current Illness:

ID: 0942790
Sex: F
Age:
State: NC

Vax Date: 01/04/2021
Onset Date: 01/04/2021
Rec V Date: 01/14/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 2
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: positive COVID-19 test with symptoms; positive COVID-19 test with symptoms; The patient had MS and was immune compromised; The patient had MS and was immune compromised; This is a spontaneous report from a contactable consumer (patient). This female consumer of unspecified age received the first single dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 04Jan2021, for COVID-19 immunization. She had MS and was immune compromised. Concomitant medications were not reported. On 07Jan2021 the patient woke up with headache, runny nose, groggy and muscle aches. She went to pharmacy and got a rapid COVID test that resulted positive. She was asking if the 1st dose could have caused her to be positive on the test. Events outcome was unknown. Information on the batch/lot number has been requested.; Sender's Comments: Based on the information available, a possible contributory role of the suspect products cannot be excluded for the reported event of positive for corona virus infection for the lack of efficacy of the vaccine. However, based on the mechanism of action of the vaccine, it is unlikely the patient would have fully developed immunity for the vaccine to be effective, due to the number of days passed since the vaccine is given. Case will be reevaluated based on follow-up information

Other Meds:

Current Illness: Immunocompromised; MS

ID: 0942791
Sex: F
Age:
State: NC

Vax Date: 01/08/2021
Onset Date: 01/08/2021
Rec V Date: 01/14/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: Itching; This is a spontaneous report from a contactable pharmacist. A 45-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), lot number: EK9231, intramuscularly in the right arm on 08Jan2021 (at the age of 45-years-old) as a single dose for COVID-19 immunization. Medical history included allergies to peanuts and shellfish, COVID-19 on an unspecified date (reported as a COVID-19 diagnosis prior to vaccination). The patient was not pregnant at the time of vaccination. Concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the vaccination. On 08Jan2021 (reported as 3 minutes after receiving the vaccine), the patient experienced itching. The patient was treated with diphenhydramine (BENADRYL) 50 mg for the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of "itching" was not resolved.

Other Meds:

Current Illness:

ID: 0942792
Sex: F
Age:
State:

Vax Date: 12/22/2020
Onset Date: 01/01/2021
Rec V Date: 01/14/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: tested COVID Positive; tested COVID Positive; This is a spontaneous report from a contactable nurse. A female patient of an unspecified age received 1st dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 22Dec2020 at single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced tested COVID positive on 01Jan2021. She still has a few symptoms and is scheduled for the 2nd dose on 12Jan2020 or 13Jan2020. She was asking if there were any recommendations on the scheduling of the vaccine for her. The outcome of event was unknown. information on the lot/batch number has been requested.; Sender's Comments: Based on the information currently available, a lack of efficacy with BNT162B2 in this patient cannot be completely excluded.

Other Meds:

Current Illness:

ID: 0942793
Sex: M
Age:
State: MI

Vax Date: 01/01/2021
Onset Date: 01/01/2021
Rec V Date: 01/14/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 026LZOA
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Vomiting

Symptoms: chills; headache; nausea; sweating; muscle and joint pain; muscle and joint pain; This is a spontaneous report from a contactable consumer communicated to a Pfizer colleague. A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on Jan2021 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced chills, headache, nausea, sweating, muscle and joint pain shortly after vaccine in Jan2021 with outcome of unknown. Was treatment received for the adverse event: unknown. Prior to vaccination, was the patient diagnosed with COVID-19: Unknown. Since the vaccination, has the patient been tested for COVID-19: Unknown. Serious: No. Seriousness criteria-Results in death: No. Seriousness criteria-Life threatening: No. Seriousness criteria-Caused/prolonged hospitalization: No. Seriousness criteria-Disabling/Incapacitating: No. Seriousness criteria-Congenital anomaly/birth defect: No.

Other Meds:

Current Illness:

ID: 0942794
Sex: F
Age:
State: IL

Vax Date: 01/07/2021
Onset Date: 01/07/2021
Rec V Date: 01/14/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: muscle soreness; This is a spontaneous report from a contactable healthcare professional. An adult female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), intramuscular on 07Jan2021 in left arm at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient was not pregnant at the time of vaccination. The patient had historical vaccine of first dose of BNT162B2 on unspecified date. The patient had no allergies to medications, food, or other products. On 07Jan2021, the patient experienced muscle soreness the day of the injection. No other symptoms were reported. No treatment was given to the patient for the event. The outcome of the event was unknown. The facility where the most recent COVID-19 vaccine was administered was in the hospital. It was unknown if the patient received any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, it was unknown if the patient was diagnosed with COVID-19. Since the vaccination, it was unknown if the patient was tested for COVID-19. The event was considered non serious as it did not results in death, was not life threatening, did not cause/prolonged hospitalization, was not disabling/Incapacitating and had no congenital anomaly/birth defect. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 0942795
Sex: F
Age:
State: AL

Vax Date: 01/07/2021
Onset Date: 01/08/2021
Rec V Date: 01/14/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: Tired; headache; achy; This is a spontaneous report from a contactable other healthcare professional (hcp). A 59-years-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot EL1283, expiry date not reported), intramuscular in the left arm on 07Jan2021 11:45 at a single dose for Covid-19 immunization. The patient had no medical history. The patient had no known allergies; no allergies to medications, food, or other products. The patient was not pregnant at the time of the vaccination. The patient had no COVID prior to vaccination (not diagnosed with COVID-19). Concomitant medication included pantoprazole. The patient had the first dose of BNT162B2 (lot EK5730, expiry date reported) for Covid-19 immunization on 17Dec2020 16:00 at a single dose in the right arm intramuscularly. The patient had no other vaccine in four weeks. Both Covid-19 vaccinations were administered in the hospital. On 08Jan2021 12:00, the patient was tired, had headache, and was achy. The events were reported as not serious (did not result in death, not life-threatening, did not cause/prolonged hospitalization, not disabling/incapacitating and not a congenital anomaly/birth defect). No treatment was received in response to the events reported. Since the vaccination (post vaccination), the patient has not been tested for COVID-19. The outcome of the events tired, headache, and achy was recovering.

Other Meds:

Current Illness:

ID: 0942796
Sex: F
Age:
State: CA

Vax Date: 01/06/2021
Onset Date: 01/06/2021
Rec V Date: 01/14/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025j20-2A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: Pain at injection site; body aches; headache; This is a spontaneous report from a contactable other health professional. A 39-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), lot number: EL3249, on 06Jan2021 at SINGLE DOSE for covid-19 immunization. The patient's medical history was not reported. Historical vaccine included BNT162B2, intramuscular from 16Dec2020 to 16Dec2020 (1st dose; lot: PAA156051). Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, has the patient has not been tested for COVID-19. There were no concomitant medications. The patient experienced pain at injection site, body aches and headache. The outcome of event was recovering. No treatment received. No follow-up attempts possible. No further information expected.

Other Meds:

Current Illness:

ID: 0942797
Sex: F
Age:
State: UT

Vax Date: 12/28/2020
Onset Date: 12/29/2020
Rec V Date: 01/14/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: Sore arm; This is a spontaneous report from a contactable nurse (patient). A 62-year-old female patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; lot EL0140, expiration date unspecified), intramuscular on 28Dec2020 at single dose at left arm for COVID-19 immunization. Medical history included depression and anxiety. The patient was not pregnant and had no known allergies. The patient had no allergies to medications, food or other products. Concomitant medications were not reported. On 29Dec2020, the patient experienced sore arm. The patient did not received therapy for the event. The most recent COVID-19 vaccine was administered at the hospital. It was reported that the patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. There were other medications the patient received within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient has not been tested for COVID-19. Outcome of event was recovered on an unspecified date.

Other Meds:

Current Illness:

ID: 0942798
Sex: F
Age:
State:

Vax Date: 01/05/2021
Onset Date: 01/01/2021
Rec V Date: 01/14/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: My armpit is swollen; Swelling in the arm; Fever; Ache; Headache; Flu like symptoms; This is a spontaneous report from a contactable Physician (patient). A 43-year-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, batch/lot number: EL1284), via an unspecified route of administration on 05Jan2021 at single dose for covid-19 immunization. Medical history included gastrooesophageal reflux disease (GERD), birth control. Concomitant medication included omeprazole for GERD, estradiol pills for birth control. The patient got the second dose of the Pfizer vaccine and she had some pretty severe flu like symptoms afterwards in Jan2021. But she noticed something odd and that was her armpit was swollen. She thought that is listed as one of the side effects but she wanted to know more about it. She had a pneumococcal vaccine (Unspecified vaccine) reaction and she wanted to make sure that there was nothing that would cross reactivity associated with this vaccine (Covid19 Vaccine). The weight is like 160. About 10 hours, she got 2 or 3 symptoms. Fever, aches, headache, bad headache. That lasted about overnight on the 05Jan2021. Swelling in the arm only started on 06Jan2021. That was when the armpit got swollen. The outcome of the events were unknown.

Other Meds: ; ESTROGEN

Current Illness:

Total 2021 VAERS Injuries: 636,615

Page last modified: 03 October 2021 5:28pm